Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P960009/S546

MEDTRONIC ACTIVA TREMOR CONTROL SYSTEM

Medtronic, Inc. · Decision date Sep 24, 2026

MEDTECHLEDGER EXPLANATIONP960009/S546

What did the FDA decide?

The FDA record for P960009/S546, dated 2026-09-24, lists an OK30 decision on a 30-day notice submitted by Medtronic, Inc. under product code MHY, device category "Stimulator, electrical, implanted, for parkinsonian tremor." The reported purpose is approval for implementation of a manufacturing process change that will update the manufacturing execution system flow for the affected feedthrough product family. The notice is categorized as a process change involving a manufacturer, sterilizer, packager, or supplier.

The supplement identifier P960009/S546 ties the notice to PMA P960009, but it is a supplement rather than a new approval of the whole Activa Tremor Control System. The record states a manufacturing-flow update for feedthroughs; it does not identify specific feedthrough part numbers, revised process parameters, validation data, or whether any design or labeling change accompanies the flow update. The statement’s reported purpose is not independent proof of safety or clinical effectiveness, and the record supplies no clinical findings.

FDA approval order statement

approval for implementation of a manufacturing process change that will update the manufacturing execution system flow for the affected feedthrough product family
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Neurology
Decision date
Sep 24, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P960009/S546
Regulatory pathway
PMA supplement
Product code
MHY
Decision code
OK30
Decision date
Sep 24, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, electrical, implanted, for parkinsonian tremor.

Product code
MHY
FDA device class
3

For the original device and its historical approval scope, see PMA P960009. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P960009 · Original PMA

    MEDTRONIC ACTIVA TREMOR CONTROL SYSTEM

  2. P960009/S546 received

    Application receipt date recorded by FDA.

  3. P960009/S546 · FDA decision

    30-Day Notice

  4. P960009/S542 · Related supplement

    Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense

  5. P960009/S547 · Related supplement

    Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (DBS Neurostimulator Implantable B35200)

  6. P960009/S548 · Related supplement

    Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense

  7. P960009/S545 · Related supplement

    Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (B32000)

Timeline entries are records held by MedtechLedger for P960009. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P960009

Explore the linked device profile

Other records with product code MHY

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementOct 30, 2026FDA
ABBOTT MEDICALPMA supplementOct 30, 2026FDA
ABBOTT MEDICALPMA supplementOct 28, 2026FDA
ABBOTT MEDICALPMA supplementOct 27, 2026FDA
Infinity DBS IPGP140009/S139
ABBOTT MEDICALPMA supplementSep 23, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
7000 Central Ave., NE, Minneapolis, MN, 55432

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records